Literature DB >> 6311749

Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

A A Weiss, E L Hewlett, G A Myers, S Falkow.   

Abstract

Transposon Tn5 was used to isolate mutants of Bordetella pertussis. Strains with Tn5 insertions were screened for loss of virulence-associated factors, including filamentous hemagglutinin, hemolysin, and pertussis toxin. Several mutants deficient for hemolysin production were obtained. All produced dermonecrotic toxin, pertussis toxin, and filamentous hemagglutinin, but were found to vary with respect to adenylate cyclase production. One hemolysin mutant had no detectable adenylate cyclase activity; others had 0.6% or 16% wild-type activity, whereas a fourth seemed to be unaffected in terms of adenylate cyclase activity. Mutants deficient in the ability to hemagglutinate sheep erythrocytes were also isolated. These mutants either failed to synthesize or produced reduced amounts of three protein species of 200,000, 130,000, and 100,000 daltons, all of which reacted with antiserum to filamentous hemagglutinin. Pertussis toxin mutants were identified by screening culture supernatants for failure to induce a clustered growth pattern in Chinese hamster ovary cells, and identification was confirmed by the standard histamine-sensitizing assay in mice. These mutants will be useful to determine the relative contribution of each virulence factor to pathogenicity as well as to determine the identity of the antigens important in protective immunity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311749      PMCID: PMC264520          DOI: 10.1128/iai.42.1.33-41.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Transposable elements in prokaryotes.

Authors:  N Kleckner
Journal:  Annu Rev Genet       Date:  1981       Impact factor: 16.830

3.  Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis.

Authors:  A A Weiss; S Falkow
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

4.  Polarity of Tn5 insertion mutations in Escherichia coli.

Authors:  D E Berg; A Weiss; L Crossland
Journal:  J Bacteriol       Date:  1980-05       Impact factor: 3.490

Review 5.  Linkage map of Escherichia coli K-12, edition 6.

Authors:  B J Bachmann; K B Low
Journal:  Microbiol Rev       Date:  1980-03

6.  Studies on Haemophilus pertussis. I. Antigen structure of H. pertussis and its phases.

Authors:  T KASUGA; Y NAKASE; K UKISHIMA; K TAKATSU
Journal:  Kitasato Arch Exp Med       Date:  1953-11

7.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.

Authors:  M Tamura; K Nogimori; S Murai; M Yajima; K Ito; T Katada; M Ui; S Ishii
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

8.  Characteristic lipids of Bordetella pertussis: simple fatty acid composition, hydroxy fatty acids, and an ornithine-containing lipid.

Authors:  Y Kawai; A Moribayashi
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

9.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

10.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

View more
  190 in total

1.  Genetic and biochemical analyses of BvgA interaction with the secondary binding region of the fha promoter of Bordetella pertussis.

Authors:  P E Boucher; M S Yang; D M Schmidt; S Stibitz
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.

Authors:  M G Barnes; A A Weiss
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

7.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

9.  DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.

Authors:  Trevor H Stenson; Alison A Weiss
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

10.  The PtlE protein of Bordetella pertussis has peptidoglycanase activity required for Ptl-mediated pertussis toxin secretion.

Authors:  Amy A Rambow-Larsen; Alison A Weiss
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.